Opportunity
Notice of Intent to Sole Source -Bode Cellmark Forensics
Response due
October 8, 2026
- Agency
- Army Med Res Acq Activity
- Estimated value
- Not stated
Key dates
- Posted
- September 24, 2026
- Response due
- October 8, 2026
Who is this buyer
Organization
Buying history
- Records20 total
- Opportunities / awards5 / 2
- Value range$132,704 – $33,358,154
- ActiveJune 26, 2026 – October 23, 2026
What they buy
- Clinical (11)
- Administrative (9)
Set-asides used
- Small Business Set Aside - Total (7)
- No Set aside used (3)
- SDVOSB Set-Aside (FAR 19.14) (2)
- 8(a) Set-Aside (FAR 19.8) (1)
Who holds their work today
- THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC.1 win · $33,358,154 · last September 1, 2023
- EZBIOME INC1 win · $132,704 · last June 25, 2025
Also open from this buyer
- BPA - Consumable Supplies for Terumo Trima Accel Blood Collection systemsDue November 6, 2026 · Clinical
- BPA - Consumable Supplies for Terumo Trima Accel Blood Collection systemsDue October 29, 2026 · Clinical
- Biomedical Research Application Evaluation and Support (BRAES)Due December 2, 2026 · Administrative
- Independent Commissioning Agent (Owner’s Advocate) Services for U.S. Army Medical Research Institute of Infectious DiseasesDue November 9, 2026 · Clinical
View source document →
Source link on sam.gov.
Source record
- Buyer type
- Federal
- Jurisdiction
- Federal (US)
- Category
- Clinical
- Set-aside
- No Set aside used
- NAICS
- 541380
- PSC
- Q301